
Publikationen von Nibal Ackl
Alle Typen
Zeitschriftenartikel (10)
1.
Zeitschriftenartikel
43, S. 702 - 710 (2009)
Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol - A double-blind multicenter trial. Journal of Psychiatric Research 2.
Zeitschriftenartikel
59, S. 858 - 862 (2006)
Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-Type dementia versus major depression. Biological Psychiatry 3.
Zeitschriftenartikel
38 (5), S. 279 - 279 (2005)
Trimipramine is equivalent to combined treatment with amitriptyline and haloperidol in patients with delusional depression. Pharmacopsychiatry 4.
Zeitschriftenartikel
384 (1-2), S. 23 - 28 (2005)
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroscience Letters 5.
Zeitschriftenartikel
39 (2), S. 173 - 177 (2005)
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. Journal of Psychiatric Research 6.
Zeitschriftenartikel
16 (3), S. 139 - 149 (2005)
Charakterisierung kognitiver Einbußen von Patienten mit "Mild Cognitive Impairment" (MCI) in der CERAD-Screeningbatterie. Zeitschrift für Neuropsychologie 7.
Zeitschriftenartikel
37 (6), S. 525 - 533 (2003)
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. Journal of Psychiatric Research 8.
Zeitschriftenartikel
36 (5), S. 210 - 210 (2003)
Evaluation of H-1-MRS as diagnostic marker for mild cognitive impairment and dementia. Pharmacopsychiatry 9.
Zeitschriftenartikel
23 (2), S. 155 - 168 (2003)
Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 10.
Zeitschriftenartikel
34, S. 171 - 181 (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R 121919 in major depression: The first 20 patients treated. Journal of Psychiatric Research